Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.

There were no significant differences in survival or SAEs based on the networks of systemic therapy delivery. This suggests that patients undergoing CRS at a high-volume center may safely receive systemic therapy at outside-network facilities with comparable outcomes.